NGNE 8-K 2026-07-01

Neurogene Inc. (NGNE) 8-K dated 2026-07-01 — accession 0001404644-26-000050. This URL is the filing, not the NGNE hub.

Neurogene Inc. (NGNE) is a biotechnology company listed on US.

Neurogene Inc. filed a 8-K on 2026-07-01. Accession 0001404644-26-000050.

Cached items: 1.01, 8.01, 9.01. EDGAR remains the official archive; Lician keeps this accession as its own indexable page so Google can recrawl the form, not a ticker dump.

Latest reported NGNE revenue for 2025-09-30 was $0. Net income was -$21.0M. NGNE currently screens at market cap $286.5M.

Not investment advice. The NGNE SEC hub lists recent forms. The stock page is the research view.